Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity
Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglo...
Saved in:
Published in | FEMS yeast research Vol. 20; no. 3; pp. 1 - 16 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. |
---|---|
AbstractList | Candida albicans has several virulence factors at its disposal, including yeast--hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 [micro]M. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 [micro]M) in combination with clotrimazole prevented biofilm formation already at 3.1 [micro]M clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 [micro]M) and clotrimazole (50 [micro]M) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 [micro]M) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 [micro]M) with clotrimazole (3.1 [micro]M) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. Candida albicans has several virulence factors at its disposal, including yeast–hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. Candida albicans has several virulence factors at its disposal, including yeast--hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 [micro]M. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 [micro]M) in combination with clotrimazole prevented biofilm formation already at 3.1 [micro]M clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 [micro]M) and clotrimazole (50 [micro]M) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 [micro]M) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 [micro]M) with clotrimazole (3.1 [micro]M) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. Keywords: antimicrobial peptides; azoles; biofilm formation; Candida albicans; LL-III derivative; virulence factors ABSTRACT Candida albicans has several virulence factors at its disposal, including yeast–hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research. |
Audience | Academic |
Author | Vaňková, Eva Čeřovský, Václav Kašparová, Petra Dulíčková, Nikola |
Author_xml | – sequence: 1 fullname: Vankova, Eva – sequence: 2 fullname: Kasparova, Petra – sequence: 3 fullname: Dulickova, Nikola – sequence: 4 fullname: Cerovsky, Vaclav |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32324227$$D View this record in MEDLINE/PubMed |
BookMark | eNptktuKFDEQhhtZcQ9666UEvFFwdnPqnm7vlsHDwIDg4TpUpyszWdLJmKRHx3fyHc2w42FlCSEV8tVPpeo_r0588FhVTxm9ZLQTVwbHtI9XJgBQTh9UZ6xu5jMmGnnyT3xanad0QymbU9o-qk4FF1xyPj-rfi7C2FuPA0FjUGcSDHGQbFi7kJL1ZLWaLZdLMmC0O8h2h-SbzRsCP4LDRGAN1qdMFuAHOwAB11sNPpGdjZNDr5EY0DnE9Jr0NhjrRmJCHItS8K_IdhNS2c5uIWEq9xgyHkJS9MgGx-D22WpSJOzO5v3j6qEBl_DJ8byovrx983nxfrb68G65uF7NtORtnkk9QCcH0UtOZVuLuWwaZGbgSOt-aFltgPYMOtO1tIby2vLGsLqFWjAcQIuL6sWtbino64Qpq9Emjc6BxzAlxUUnuWw60RT0-X_oTZiiL9Wp0uK6kZwx-Zdag0NlvQk5gj6Iqus5ZbXsaMcKdXkPVdaAo9Vl8KV_eDfh5Z2EwmT8ntcwpaSWnz7eK65jmWxEo7bRjhD3ilF18JK69ZI6eqkkPDv-bOpHHP7gv80jfgE83Mnp |
CitedBy_id | crossref_primary_10_1371_journal_pone_0272844 crossref_primary_10_1016_j_micpath_2024_106613 crossref_primary_10_3390_pharmaceutics15030789 crossref_primary_10_1155_2023_5645500 crossref_primary_10_3389_fbioe_2022_815393 crossref_primary_10_1007_s10989_022_10401_5 crossref_primary_10_1134_S0006350922020178 crossref_primary_10_1007_s11274_020_02891_6 crossref_primary_10_1080_21655979_2021_1933824 crossref_primary_10_3390_ijms23169264 crossref_primary_10_1007_s12223_021_00898_6 crossref_primary_10_3389_fcimb_2022_993029 crossref_primary_10_1007_s00726_023_03326_w crossref_primary_10_3390_ph15050534 |
Cites_doi | 10.1128/CMR.15.2.167-193.2002 10.1016/j.tibtech.2011.05.001 10.1146/annurev-micro-091014-104330 10.1002/cbic.200900133 10.1016/j.micres.2018.08.012 10.1128/AAC.49.7.2583-2588.2005 10.1111/j.1348-0421.1996.tb01147.x 10.1016/j.drup.2004.09.002 10.1099/jmm.0.001000 10.1016/S0378-1097(00)00071-9 10.3390/molecules201017913 10.1016/j.bbamem.2009.06.008 10.1002/psc.2827 10.1007/s10856-012-4645-z 10.1016/j.archoralbio.2006.12.008 10.1371/journal.pone.0132701 10.1016/S0960-894X(98)00084-5 10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M 10.1093/jac/dkn393 10.1023/A:1026572128004 10.5114/pdia.2013.38358 10.1128/CMR.00056-05 10.1016/j.bbamem.2014.11.024 10.1128/mBio.01991-17 10.1016/j.mycmed.2017.12.011 10.1016/j.ijantimicag.2009.11.021 10.1046/j.1439-0507.2001.00685.x 10.1111/1348-0421.12538 10.1128/JB.183.18.5385-5394.2001 10.1128/JCM.39.8.2971-2974.2001 10.3389/fmicb.2017.02218 10.1023/B:BILE.0000015472.09542.6d 10.1016/S0966-842X(00)01913-2 10.1021/acs.jnatprod.5b01129 10.1128/AAC.01777-18 10.1002/ctpp.201800044 10.1016/j.bbrc.2012.11.015 10.1080/21505594.2015.1039885 10.3389/fmicb.2016.01844 10.2478/s11535-010-0111-4 10.1016/j.peptides.2014.09.021 10.1016/j.tips.2019.04.012 10.1016/j.peptides.2015.07.023 10.1016/j.phymed.2014.11.019 10.1590/0037-8682-0032-2017 10.1016/j.archoralbio.2005.11.007 10.1016/j.peptides.2015.11.001 10.1093/jac/44.5.641 10.1093/femsyr/foz013 10.1111/cmi.13093 10.3389/fmicb.2016.01783 10.1128/AAC.02381-14 10.1016/j.cbpa.2017.03.014 10.1128/AAC.43.11.2635 10.1128/AAC.03065-15 10.1038/nature17625 10.1016/S0006-291X(03)00755-1 10.1016/j.pdpdt.2018.04.016 10.1007/978-3-319-50409-4_5 10.1039/C5RA14862F 10.1007/s00294-013-0400-3 10.1039/c3ra40887f 10.3389/fped.2019.00375 10.3389/fmicb.2017.02051 10.1002/pola.29078 10.1093/cid/cis697 10.1016/0378-1119(93)90668-S 10.1179/1973947812Y.0000000007 10.1007/s00253-009-1879-x 10.3109/13693780902801242 10.1016/j.jbiotec.2016.06.023 10.1007/s00726-010-0519-1 |
ContentType | Journal Article |
Copyright | FEMS 2020. COPYRIGHT 2020 Oxford University Press |
Copyright_xml | – notice: FEMS 2020. – notice: COPYRIGHT 2020 Oxford University Press |
DBID | NPM AAYXX CITATION ISR 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1093/femsyr/foaa020 |
DatabaseName | PubMed CrossRef Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student PubMed CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1567-1364 |
ExternalDocumentID | A701549091 10_1093_femsyr_foaa020 32324227 |
Genre | Journal Article |
GeographicLocations | Czech Republic |
GeographicLocations_xml | – name: Czech Republic |
GroupedDBID | --- .3N .GA 0R~ 10A 1OC 29H 36B 4.4 48X 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 8FI 8FJ 8UM 930 A03 AAHBH AAIMJ AAMDB AAMVS AAOGV AAPQZ AAPXW AARHZ AAUQX AAVAP ABCQN ABEML ABEUO ABIXL ABJNI ABPTD ABQLI ABUWG ABXVV ACGFO ACGFS ACPRK ACSCC ACUFI ADBBV ADEZT ADGZP ADHKW ADHZD ADQBN ADRIX ADRTK ADVEK ADYVW AEGPL AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFKRA AFOFC AFXEN AGINJ AGSYK AJEEA AKWXX ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ARIXL AVWKF AXUDD AYOIW AZBYB BAFTC BAYMD BBNVY BCRHZ BENPR BEYMZ BHONS BHPHI BPHCQ BQDIO BSWAC CCPQU CDBKE CS3 D-E D-F DAKXR DCZOG DILTD DR2 DU5 EBS EMB F00 F01 F04 F5P FDB FHSFR FLUFQ FOEOM FYUFA G-S G.N GAUVT GJXCC H13 HAR HCIFZ HMCUK HZI HZ~ IAO IHR ISR ITC IX1 J21 K48 KBUDW KOP KSI KSN LC2 LC3 LP6 LP7 M1P M7P MK4 N04 N05 N9A NLBLG NOMLY NPM O9- OAWHX ODMLO OIG OJQWA P2P P2X P4D PAFKI PEELM PROAC PSQYO Q.N Q11 Q5Y QB0 R.K ROL ROX RPM RUSNO RX1 RXO TLC TOX UB1 UKHRP V8K W8V W99 WQJ XG1 YAYTL YKOAZ YXANX ~IA ~KM ~WT AASNB AAYXX CITATION OVD ABEJV AABJS AABMN AAESY AAIYJ ADEIU ADORX ADQLU AIKOY AZQFJ BY8 BYORX CASEJ DPPUQ OJZSN TEORI 3V. 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PQEST PQQKQ PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c428t-4cda94d3b42048537466e1fd2e05bd815fa0b1a9f9805a746826f158a531edac3 |
IEDL.DBID | 7X7 |
ISSN | 1567-1364 1567-1356 |
IngestDate | Fri Oct 25 07:58:50 EDT 2024 Thu Oct 10 18:41:29 EDT 2024 Thu Feb 22 23:47:26 EST 2024 Tue Nov 12 23:22:21 EST 2024 Thu Aug 01 19:19:01 EDT 2024 Thu Sep 26 17:00:01 EDT 2024 Wed Oct 16 00:46:19 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Candida albicans biofilm formation azoles antimicrobial peptides virulence factors LL-III derivative |
Language | English |
License | FEMS 2020. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-4cda94d3b42048537466e1fd2e05bd815fa0b1a9f9805a746826f158a531edac3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8863-0696 0000-0003-4184-2848 0000-0003-2182-0430 |
OpenAccessLink | https://academic.oup.com/femsyr/article-pdf/20/3/foaa020/38875885/foaa020.pdf |
PMID | 32324227 |
PQID | 2425642114 |
PQPubID | 2044077 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_2394246936 proquest_journals_2425642114 gale_infotracmisc_A701549091 gale_infotracacademiconefile_A701549091 gale_incontextgauss_ISR_A701549091 crossref_primary_10_1093_femsyr_foaa020 pubmed_primary_32324227 |
PublicationCentury | 2000 |
PublicationDate | 2020-May-01 2020-05-01 20200501 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-May-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Hoboken |
PublicationTitle | FEMS yeast research |
PublicationTitleAlternate | FEMS Yeast Res |
PublicationYear | 2020 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Galan-Ladero (2021070701263330000_bib17) 2010; 48 Vriens (2021070701263330000_bib71) 2015; 10 Mishra (2021070701263330000_bib43) 2017; 38 Jiang (2021070701263330000_bib24) 2012; 23 Viejo-Díaz (2021070701263330000_bib68) 2005; 49 Bandyopadhyay (2021070701263330000_bib1) 2013; 430 Ma (2021070701263330000_bib37) 2015; 20 Mah (2021070701263330000_bib38) 2001; 9 Nguyen (2021070701263330000_bib50) 2011; 29 Slaninová (2021070701263330000_bib59) 2015; 11 Orlandi (2021070701263330000_bib53) 2018; 22 Kodedová (2021070701263330000_bib28) 2019; 21 Vriens (2021070701263330000_bib72) 2016; 75 Koehbach (2021070701263330000_bib29) 2019; 40 Čeřovský (2021070701263330000_bib11) 2009; 10 Luo (2021070701263330000_bib36) 2001; 39 Nett (2021070701263330000_bib49) 2014; 12 Park (2021070701263330000_bib54) 2009; 1788 Marcos-Zambrano (2021070701263330000_bib39) 2016; 60 Löffler (2021070701263330000_bib35) 2000; 185 Giacometti (2021070701263330000_bib18) 1999; 44 Clinical, Institute LS (2021070701263330000_bib8) 2017 Donlan (2021070701263330000_bib12) 2002; 15 Moyes (2021070701263330000_bib46) 2016; 532 Uppuluri (2021070701263330000_bib65) 2017 Basu (2021070701263330000_bib2) 2015; 5 Kovács (2021070701263330000_bib30) 2019; 63 Mariscal (2021070701263330000_bib40) 2009; 82 Dosler (2021070701263330000_bib13) 2012; 24 Monincová (2021070701263330000_bib44) 2010; 39 Issam (2021070701263330000_bib22) 2015; 22 Chandra (2021070701263330000_bib21) 2001; 183 Lee (2021070701263330000_bib32) 2004; 26 Paula-Mattiello (2021070701263330000_bib55) 2017; 50 Niewerth (2021070701263330000_bib51) 2001; 44 Cirioni (2021070701263330000_bib6) 2008; 62 Guilhelmelli (2021070701263330000_bib19) 2016; 7 Cleveland (2021070701263330000_bib7) 2012; 55 Wakabayashi (2021070701263330000_bib73) 1996; 40 Cools (2021070701263330000_bib9) 2017; 8 Tan (2021070701263330000_bib62) 2018; 216 Troskie (2021070701263330000_bib64) 2014; 58 Mishra (2021070701263330000_bib42) 2013; 3 Scarsini (2021070701263330000_bib58) 2015; 71 Vráblíková (2021070701263330000_bib70) 2017; 61 Cui (2021070701263330000_bib10) 2015; 6 Lee (2021070701263330000_bib34) 2015; 1848 Jenssen (2021070701263330000_bib23) 2006; 19 Bondaryk (2021070701263330000_bib4) 2013; 30 Mukherjee (2021070701263330000_bib47) 2004; 7 Polaquini (2021070701263330000_bib56) 2006; 51 Slaninová (2021070701263330000_bib60) 2011; 6 Van't Hof (2021070701263330000_bib67) 2000; 78 Volejníková (2021070701263330000_bib69) 2019; 68 Zuza-Alves (2021070701263330000_bib77) 2016; 7 Mathé (2021070701263330000_bib41) 2013; 59 Romo (2021070701263330000_bib57) 2017; 8 Tossi (2021070701263330000_bib63) 2000; 55 Harris (2021070701263330000_bib20) 2010; 35 Vaňková (2021070701263330000_bib66) 2019; 59 Weber (2021070701263330000_bib74) 1998; 8 Kodedová (2021070701263330000_bib27) 2016; 233 Zaccaria (2021070701263330000_bib76) 2018; 56 Kuipers (2021070701263330000_bib31) 1999; 43 Mora-Navarro (2021070701263330000_bib45) 2015; 21 Bersani (2021070701263330000_bib3) 2019; 7 Yang (2021070701263330000_bib75) 2018; 28 Srikantha (2021070701263330000_bib61) 1993; 131 Dosler (2021070701263330000_bib14) 2014; 62 Kadir (2021070701263330000_bib25) 2007; 52 Nešuta (2021070701263330000_bib48) 2016; 79 Lee (2021070701263330000_bib33) 2003; 305 Fais (2021070701263330000_bib16) 2017; 8 Nobile (2021070701263330000_bib52) 2015; 69 Brogden (2021070701263330000_bib5) 2011; 38 Douglas (2021070701263330000_bib15) 2002; 19 Kočendová (2021070701263330000_bib26) 2019; 19 |
References_xml | – volume: 15 start-page: 167 year: 2002 ident: 2021070701263330000_bib12 article-title: Biofilms: survival mechanisms of clinically relevant microorganisms publication-title: Clin Microbiol Rev doi: 10.1128/CMR.15.2.167-193.2002 contributor: fullname: Donlan – volume: 29 start-page: 464 year: 2011 ident: 2021070701263330000_bib50 article-title: The expanding scope of antimicrobial peptide structures and their modes of action publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2011.05.001 contributor: fullname: Nguyen – volume: 69 start-page: 71 year: 2015 ident: 2021070701263330000_bib52 article-title: Candida albicans biofilms and human disease publication-title: Annu Rev Microbiol doi: 10.1146/annurev-micro-091014-104330 contributor: fullname: Nobile – volume: 10 start-page: 2089 year: 2009 ident: 2021070701263330000_bib11 article-title: Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae) publication-title: ChemBioChem doi: 10.1002/cbic.200900133 contributor: fullname: Čeřovský – volume: 11 start-page: 113 year: 2015 ident: 2021070701263330000_bib59 article-title: Candida species and antimicrobial peptides from the venom of different wild bees publication-title: Collect Czech Chem C contributor: fullname: Slaninová – volume: 216 start-page: 120 year: 2018 ident: 2021070701263330000_bib62 article-title: Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis publication-title: Microbiol Res doi: 10.1016/j.micres.2018.08.012 contributor: fullname: Tan – volume: 49 start-page: 2583 year: 2005 ident: 2021070701263330000_bib68 article-title: Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1 publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.49.7.2583-2588.2005 contributor: fullname: Viejo-Díaz – volume: 40 start-page: 821 year: 1996 ident: 2021070701263330000_bib73 article-title: Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1996.tb01147.x contributor: fullname: Wakabayashi – volume: 7 start-page: 301 year: 2004 ident: 2021070701263330000_bib47 article-title: Candida biofilm resistance publication-title: Drug Resist Updat doi: 10.1016/j.drup.2004.09.002 contributor: fullname: Mukherjee – volume: 68 start-page: 961 year: 2019 ident: 2021070701263330000_bib69 article-title: Antimicrobial peptides prevent bacterial biofilm formation on the surface of polymethylmethacrylate bone cement publication-title: J Med Microbiol doi: 10.1099/jmm.0.001000 contributor: fullname: Volejníková – volume: 185 start-page: 59 year: 2000 ident: 2021070701263330000_bib35 article-title: Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains publication-title: FEMS Microbiol Lett doi: 10.1016/S0378-1097(00)00071-9 contributor: fullname: Löffler – volume: 20 start-page: 17913 year: 2015 ident: 2021070701263330000_bib37 article-title: Potent activities of roemerine against Candida albicans and the underlying mechanisms publication-title: Molecules doi: 10.3390/molecules201017913 contributor: fullname: Ma – volume: 1788 start-page: 1790 year: 2009 ident: 2021070701263330000_bib54 article-title: Fungicidal effect of antimicrobial peptide arenicin-1 publication-title: BBA-Rev Biomembranes doi: 10.1016/j.bbamem.2009.06.008 contributor: fullname: Park – volume: 21 start-page: 853 year: 2015 ident: 2021070701263330000_bib45 article-title: Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans publication-title: J Pept Sci doi: 10.1002/psc.2827 contributor: fullname: Mora-Navarro – volume: 23 start-page: 1723 year: 2012 ident: 2021070701263330000_bib24 article-title: Antimicrobial activities of recombinant mouse β-defensin 3 and its synergy with antibiotics publication-title: J Mater Sci-Mater M doi: 10.1007/s10856-012-4645-z contributor: fullname: Jiang – volume: 52 start-page: 691 year: 2007 ident: 2021070701263330000_bib25 article-title: Phospholipase activity of Candida albicans isolates from patients with denture stomatitis: the influence of chlorhexidine gluconate on phospholipase production publication-title: Arch Oral Biol doi: 10.1016/j.archoralbio.2006.12.008 contributor: fullname: Kadir – volume: 10 start-page: 1 year: 2015 ident: 2021070701263330000_bib71 article-title: Synergistic activity of the plant defensin HsAFP1 and caspofungin against Candida albicans biofilms and planktonic cultures publication-title: PLoS One doi: 10.1371/journal.pone.0132701 contributor: fullname: Vriens – volume: 8 start-page: 597 year: 1998 ident: 2021070701263330000_bib74 article-title: A fast and inexpensive method for N-terminal fluorescein-labeling of peptides publication-title: Bioorg Med Chem Lett doi: 10.1016/S0960-894X(98)00084-5 contributor: fullname: Weber – volume: 12 start-page: 375 year: 2014 ident: 2021070701263330000_bib49 article-title: Future directions for anti-biofilm therapeutics targeting Candida. Expert Rev publication-title: Anti-Infe contributor: fullname: Nett – volume: 55 start-page: 4 year: 2000 ident: 2021070701263330000_bib63 article-title: Amphipathic, α-helical antimicrobial peptides publication-title: Pept Sci doi: 10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M contributor: fullname: Tossi – volume: 62 start-page: 1332 year: 2008 ident: 2021070701263330000_bib6 article-title: Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection publication-title: J Antimicrobiol Chemoth doi: 10.1093/jac/dkn393 contributor: fullname: Cirioni – volume: 78 start-page: 163 year: 2000 ident: 2021070701263330000_bib67 article-title: Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity publication-title: Antonie Van Leeuwenhoek doi: 10.1023/A:1026572128004 contributor: fullname: Van't Hof – volume: 30 start-page: 293 year: 2013 ident: 2021070701263330000_bib4 article-title: Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development publication-title: Adv Dermatol Allergol doi: 10.5114/pdia.2013.38358 contributor: fullname: Bondaryk – volume: 19 start-page: 491 year: 2006 ident: 2021070701263330000_bib23 article-title: Peptide antimicrobial agents publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00056-05 contributor: fullname: Jenssen – volume: 1848 start-page: 673 year: 2015 ident: 2021070701263330000_bib34 article-title: Fungicidal mechanisms of the antimicrobial peptide Bac8c publication-title: BBA-Rev Biomembranes doi: 10.1016/j.bbamem.2014.11.024 contributor: fullname: Lee – volume: 8 start-page: 1 year: 2017 ident: 2021070701263330000_bib57 article-title: Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation publication-title: mBio doi: 10.1128/mBio.01991-17 contributor: fullname: Romo – volume: 28 start-page: 36 year: 2018 ident: 2021070701263330000_bib75 article-title: Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans publication-title: J Mycol Med doi: 10.1016/j.mycmed.2017.12.011 contributor: fullname: Yang – volume: 35 start-page: 347 year: 2010 ident: 2021070701263330000_bib20 article-title: Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro publication-title: Int J Antimicrob Ag doi: 10.1016/j.ijantimicag.2009.11.021 contributor: fullname: Harris – volume: 44 start-page: 361 year: 2001 ident: 2021070701263330000_bib51 article-title: Phospholipases of Candida albicans publication-title: Mycoses doi: 10.1046/j.1439-0507.2001.00685.x contributor: fullname: Niewerth – volume: 61 start-page: 474 year: 2017 ident: 2021070701263330000_bib70 article-title: Lasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice publication-title: Microbiol Immunol doi: 10.1111/1348-0421.12538 contributor: fullname: Vráblíková – volume: 183 start-page: 5385 year: 2001 ident: 2021070701263330000_bib21 article-title: Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance publication-title: J Bacteriol doi: 10.1128/JB.183.18.5385-5394.2001 contributor: fullname: Chandra – volume: 39 start-page: 2971 year: 2001 ident: 2021070701263330000_bib36 article-title: Candida species exhibit differential in vitro hemolytic activities publication-title: J Clin Microbiol doi: 10.1128/JCM.39.8.2971-2974.2001 contributor: fullname: Luo – volume: 8 start-page: 1 year: 2017 ident: 2021070701263330000_bib16 article-title: The N-terminus of human lactoferrin displays anti-biofilm activity on Candida parapsilosis in lumen catheters publication-title: Front Microbiol doi: 10.3389/fmicb.2017.02218 contributor: fullname: Fais – volume: 26 start-page: 337 year: 2004 ident: 2021070701263330000_bib32 article-title: Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides publication-title: Biotechnol Lett doi: 10.1023/B:BILE.0000015472.09542.6d contributor: fullname: Lee – volume: 9 start-page: 34 year: 2001 ident: 2021070701263330000_bib38 article-title: Mechanisms of biofilm resistance to antimicrobial agents publication-title: Trends Microbiol doi: 10.1016/S0966-842X(00)01913-2 contributor: fullname: Mah – volume: 79 start-page: 1073 year: 2016 ident: 2021070701263330000_bib48 article-title: Antimicrobial peptide from the wild Bee Hylaeus signatus venom and its analogues: structure–activity study and synergistic effect with antibiotics publication-title: J Nat Prod doi: 10.1021/acs.jnatprod.5b01129 contributor: fullname: Nešuta – volume: 63 start-page: e01777 year: 2019 ident: 2021070701263330000_bib30 article-title: In vivo applicability of Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment of vulvovaginal candidiasis publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.01777-18 contributor: fullname: Kovács – volume: 59 start-page: 166 year: 2019 ident: 2021070701263330000_bib66 article-title: Prevention of biofilm re-development on Ti-6Al-4 V alloy by cometary discharge with a metallic grid publication-title: Contrib Plasm Phys doi: 10.1002/ctpp.201800044 contributor: fullname: Vaňková – volume: 430 start-page: 1 year: 2013 ident: 2021070701263330000_bib1 article-title: Model membrane interaction and DNA-binding of antimicrobial peptide Lasioglossin II derived from bee venom publication-title: Biochem Bioph Res Co doi: 10.1016/j.bbrc.2012.11.015 contributor: fullname: Bandyopadhyay – volume: 6 start-page: 362 year: 2015 ident: 2021070701263330000_bib10 article-title: Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans publication-title: Virulence doi: 10.1080/21505594.2015.1039885 contributor: fullname: Cui – volume: 7 start-page: 1 year: 2016 ident: 2021070701263330000_bib19 article-title: Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01844 contributor: fullname: Guilhelmelli – volume: 6 start-page: 150 year: 2011 ident: 2021070701263330000_bib60 article-title: The antifungal effect of peptides from hymenoptera venom and their analogs publication-title: Open Life Sci doi: 10.2478/s11535-010-0111-4 contributor: fullname: Slaninová – volume: 62 start-page: 32 year: 2014 ident: 2021070701263330000_bib14 article-title: Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides publication-title: Peptides doi: 10.1016/j.peptides.2014.09.021 contributor: fullname: Dosler – volume: 40 start-page: 517 year: 2019 ident: 2021070701263330000_bib29 article-title: The vast structural diversity of antimicrobial peptides publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2019.04.012 contributor: fullname: Koehbach – volume: 71 start-page: 211 year: 2015 ident: 2021070701263330000_bib58 article-title: Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections publication-title: Peptides doi: 10.1016/j.peptides.2015.07.023 contributor: fullname: Scarsini – volume: 22 start-page: 245 year: 2015 ident: 2021070701263330000_bib22 article-title: Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens publication-title: Phytomedicine doi: 10.1016/j.phymed.2014.11.019 contributor: fullname: Issam – volume-title: Performance Standards for Antifungal Susceptibility Testing of Yeasts year: 2017 ident: 2021070701263330000_bib8 contributor: fullname: Clinical, Institute LS – volume: 50 start-page: 558 year: 2017 ident: 2021070701263330000_bib55 article-title: In vitro evaluation of hydrolytic enzyme activity and biofilm formation of Candida parapsilosis species complex from a nosocomial environment publication-title: Rev Soc Bras Med Tro doi: 10.1590/0037-8682-0032-2017 contributor: fullname: Paula-Mattiello – volume: 51 start-page: 482 year: 2006 ident: 2021070701263330000_bib56 article-title: Effect of aqueous extract from Neem (Azadirachta indica A. Juss) on hydrophobicity, biofilm formation and adhesion in composite resin by Candida albicans. Arch publication-title: Oral Biol doi: 10.1016/j.archoralbio.2005.11.007 contributor: fullname: Polaquini – volume: 75 start-page: 71 year: 2016 ident: 2021070701263330000_bib72 article-title: The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms publication-title: Peptides doi: 10.1016/j.peptides.2015.11.001 contributor: fullname: Vriens – volume: 44 start-page: 641 year: 1999 ident: 2021070701263330000_bib18 article-title: In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa publication-title: J Antimicrobiol Chemoth doi: 10.1093/jac/44.5.641 contributor: fullname: Giacometti – volume: 19 start-page: 1 year: 2019 ident: 2021070701263330000_bib26 article-title: Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp publication-title: FEMS Yeast Res doi: 10.1093/femsyr/foz013 contributor: fullname: Kočendová – volume: 21 start-page: 1 year: 2019 ident: 2021070701263330000_bib28 article-title: Variations in yeast plasma-membrane lipid composition affect killing activity of three families of insect antifungal peptides publication-title: Cell Microbiol doi: 10.1111/cmi.13093 contributor: fullname: Kodedová – volume: 7 start-page: 1 year: 2016 ident: 2021070701263330000_bib77 article-title: Evaluation of virulence factors in vitro, resistance to osmotic stress and antifungal susceptibility of Candida tropicalis isolated from the coastal environment of Northeast Brazil publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01783 contributor: fullname: Zuza-Alves – volume: 58 start-page: 3697 year: 2014 ident: 2021070701263330000_bib64 article-title: Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.02381-14 contributor: fullname: Troskie – volume: 38 start-page: 87 year: 2017 ident: 2021070701263330000_bib43 article-title: Host defense antimicrobial peptides as antibiotics: design and application strategies publication-title: Curr Opin Chem Biol doi: 10.1016/j.cbpa.2017.03.014 contributor: fullname: Mishra – volume: 43 start-page: 2635 year: 1999 ident: 2021070701263330000_bib31 article-title: Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.43.11.2635 contributor: fullname: Kuipers – volume: 60 start-page: 3579 year: 2016 ident: 2021070701263330000_bib39 article-title: Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.03065-15 contributor: fullname: Marcos-Zambrano – volume: 532 start-page: 64 year: 2016 ident: 2021070701263330000_bib46 article-title: Candidalysin is a fungal peptide toxin critical for mucosal infection publication-title: Nature doi: 10.1038/nature17625 contributor: fullname: Moyes – volume: 305 start-page: 305 year: 2003 ident: 2021070701263330000_bib33 article-title: Fungicidal effect of indolicidin and its interaction with phospholipid membranes publication-title: Biochem Bioph Res Co doi: 10.1016/S0006-291X(03)00755-1 contributor: fullname: Lee – volume: 38 start-page: 217 year: 2011 ident: 2021070701263330000_bib5 article-title: Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? publication-title: Int J Antimicrob Ag contributor: fullname: Brogden – volume: 19 start-page: 139 year: 2002 ident: 2021070701263330000_bib15 article-title: Medical importance of biofilms in Candida infections publication-title: Rev Iberoam Micol contributor: fullname: Douglas – volume: 22 start-page: 233 year: 2018 ident: 2021070701263330000_bib53 article-title: Catalase A is involved in the response to photooxidative stress in Pseudomonas aeruginosa. Photodiagn publication-title: Photodyn doi: 10.1016/j.pdpdt.2018.04.016 contributor: fullname: Orlandi – start-page: 63 volume-title: Candida albicans: Cellular and Molecular Biology year: 2017 ident: 2021070701263330000_bib65 article-title: Candida albicans Biofilms doi: 10.1007/978-3-319-50409-4_5 contributor: fullname: Uppuluri – volume: 5 start-page: 78712 year: 2015 ident: 2021070701263330000_bib2 article-title: Global transcriptome analysis reveals distinct bacterial response towards soluble and surface-immobilized antimicrobial peptide (Lasioglossin-III) publication-title: RSC Adv doi: 10.1039/C5RA14862F contributor: fullname: Basu – volume: 59 start-page: 251 year: 2013 ident: 2021070701263330000_bib41 article-title: Recent insights into Candida albicans biofilm resistance mechanisms publication-title: Curr Genet doi: 10.1007/s00294-013-0400-3 contributor: fullname: Mathé – volume: 3 start-page: 9534 year: 2013 ident: 2021070701263330000_bib42 article-title: Lasioglossin-III: antimicrobial characterization and feasibility study for immobilization applications publication-title: RSC Adv doi: 10.1039/c3ra40887f contributor: fullname: Mishra – volume: 7 start-page: 375 year: 2019 ident: 2021070701263330000_bib3 article-title: Antifungal drugs for invasive Candida infections (ICI) in neonates: future perspectives publication-title: Front Pediatr doi: 10.3389/fped.2019.00375 contributor: fullname: Bersani – volume: 8 start-page: 1 year: 2017 ident: 2021070701263330000_bib9 article-title: A linear 19-mer plant defensin-derived peptide acts synergistically with caspofungin against Candida albicans biofilms publication-title: Front Microbiol doi: 10.3389/fmicb.2017.02051 contributor: fullname: Cools – volume: 56 start-page: 1926 year: 2018 ident: 2021070701263330000_bib76 article-title: Antimicrobial peptide modification of biomaterials using supramolecular additives publication-title: J Polym Sci A1 doi: 10.1002/pola.29078 contributor: fullname: Zaccaria – volume: 55 start-page: 1352 year: 2012 ident: 2021070701263330000_bib7 article-title: Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011 publication-title: Clin Infect Dis doi: 10.1093/cid/cis697 contributor: fullname: Cleveland – volume: 131 start-page: 53 year: 1993 ident: 2021070701263330000_bib61 article-title: A white-specific gene in the white-opaque switching system of Candida albicans publication-title: Gene doi: 10.1016/0378-1119(93)90668-S contributor: fullname: Srikantha – volume: 24 start-page: 137 year: 2012 ident: 2021070701263330000_bib13 article-title: In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria publication-title: J Chemotherapy doi: 10.1179/1973947812Y.0000000007 contributor: fullname: Dosler – volume: 82 start-page: 773 year: 2009 ident: 2021070701263330000_bib40 article-title: Fluorescent assay based on resazurin for detection of activity of disinfectants against bacterial biofilm publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-009-1879-x contributor: fullname: Mariscal – volume: 48 start-page: 207 year: 2010 ident: 2021070701263330000_bib17 article-title: Enzymatic activities of Candida tropicalis isolated from hospitalized patients publication-title: Med Mycol doi: 10.3109/13693780902801242 contributor: fullname: Galan-Ladero – volume: 233 start-page: 26 year: 2016 ident: 2021070701263330000_bib27 article-title: High-throughput fluorescence screening assay for the identification and comparison of antimicrobial peptides’ activity on various yeast species publication-title: J Biotechnol doi: 10.1016/j.jbiotec.2016.06.023 contributor: fullname: Kodedová – volume: 39 start-page: 763 year: 2010 ident: 2021070701263330000_bib44 article-title: Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs publication-title: Amino Acids doi: 10.1007/s00726-010-0519-1 contributor: fullname: Monincová |
SSID | ssj0017008 |
Score | 2.3883286 |
Snippet | Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases... ABSTRACT Candida albicans has several virulence factors at its disposal, including yeast–hyphal transition associated with biofilm formation, phospholipases,... Candida albicans has several virulence factors at its disposal, including yeast--hyphal transition associated with biofilm formation, phospholipases, proteases... Candida albicans has several virulence factors at its disposal, including yeast–hyphal transition associated with biofilm formation, phospholipases, proteases... |
SourceID | proquest gale crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Antimicrobial agents Antimicrobial peptides Azoles Biofilms Bone surgery Candida albicans Catheters Clotrimazole Mushrooms Peptides Phospholipases Proteases Scanning electron microscopy Surgery Virulence factors |
Title | Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32324227 https://www.proquest.com/docview/2425642114 https://search.proquest.com/docview/2394246936 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIviO8VxnQgJF6ImsR2PnhBY2xa0ZhQYVLfIjuxu0htUpp2Uvmf-B-5c9JA98BDpKR23ER3Pt85d78fY2_jlICqQutZkXBPaJRFaqTvGWEjFQcmjxx929fL6PxKfJnISbfh1nRplVub6Ax1Uee0Rz4k15iKMgPxcfHTI9Yo-rraUWjcZftB6EeU0hVP-oCLoOdcKZxEYxBwGfWgjXxozbzZLIe2Vsonru9_FqXbpvmWw-kWnrOH7EHnMcJxK-JH7I6pHrN7LYfk5gn7jTMao1tTQJuaAbUFKo2spzP8q7KCiwtvNBpBgap241C-gfZeQf0iKCdQU1WihwgnVN5SKFAzTYaxgZtyuXYFSdBR8nwAXRK_9xz6gsf3sLiuGzxm5QJXwwavCfaBTgHHg2szr2cbfG6g8gliqXjKrs5Of5ycex0Hg5djYLLyRF6oVBRcC0L4lTwWUWQCW4TGl7pIAmmVrwOV2jTxpcJWDFdsIBOFc9sUKufP2F5VV-aAgdRpmkvUGGu18LVQ2hc5LqH4c6K5Hw7Yu60QskULtZG1n8h51oor68Q1YG9IRhnhV1SUIDNV66bJRt_H2XHsQOfQC8Lhuk62Xi1Vrrp6A3wYgrza6Xm40xMnWL7bvFWFrJvgTfZXHQfsdd9Md1LSWmXqNfbhqQhFlPJowJ63KtS_GHeebBi_-P_gL9n9kAJ8l2F5yPZWy7V5hV7QSh85VT9i-59OL7-N8erzOPwDg_0MBg |
link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYIL4rkUFjAIiQtRk9jOgwtarVg10N0D7Eq9WXZidyu1SWnalcp_4j8y47iB7oFDpTR2nEQzHs84M99HyPs0R6Cq2AaWZyzgGmSRGxEGhttEpZEpE0ffdnaejC7514mY-A231qdV7myiM9RVU-Ie-RBdYyzKjPjn5c8AWaPw66qn0LhN7iAOFzIYpJM-4ELoOVcKJ8AYREwkPWgjG1qzaLeroW2UCpHr-59F6aZpvuFwuoXn9CF54D1GetyJ-BG5ZerH5G7HIbl9Qn7DjIbo1lS0S82gjaVYGtlM53CrWU3H46AoClqBql07lG-Ke69U_UIoJ6qmagYeIj3B8pZKUTXXaBhbej1bbVxBEvWUPJ-oniG_94L2BY8f6fKqaeE3ny1hNWzhP8I-4CGF8eiVWTTzLTw3xfIJZKl4Si5Pv1ycjALPwRCUEJisA15WKucV0xwRfgVLeZKYyFaxCYWuskhYFepI5TbPQqGgFcIVG4lMwdw2lSrZM3JQN7V5TqjQeV4K0BhrNQ81VzrkJSyhcDrTLIwH5MNOCHLZQW3I7hM5k524pBfXgLxDGUnEr6gxQWaqNm0rix_f5XHqQOfAC4LhfCfbrFeqVL7eAB4GIa_2eh7t9YQJVu4371RB-gneyr_qOCBv-2a8EpPWatNsoA_LecyTnCUDctipUP9izHmycfri_4O_IfdGF2djOS7Ov70k92MM9l225RE5WK825hV4RGv92qn9H3jqDGo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+effect+of+lasioglossin+LL-III+derivative+with+azoles+against+Candida+albicans+virulence+factors%3A+biofilm+formation%2C+phospholipases%2C+proteases+and+hemolytic+activity&rft.jtitle=FEMS+yeast+research&rft.au=Va%C5%88kov%C3%A1%2C+Eva&rft.au=Ka%C5%A1parov%C3%A1%2C+Petra&rft.au=Dul%C3%AD%C4%8Dkov%C3%A1%2C+Nikola&rft.au=%C4%8Ce%C5%99ovsk%C3%BD%2C+V%C3%A1clav&rft.date=2020-05-01&rft.issn=1567-1364&rft.eissn=1567-1364&rft.volume=20&rft.issue=3&rft_id=info:doi/10.1093%2Ffemsyr%2Ffoaa020&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_femsyr_foaa020 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-1364&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-1364&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-1364&client=summon |